Results

Total Results: 272 records

Showing results for "end stage renal".

161. Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
     August 27, 2012 - Before we begin I would like to set the stage for why we felt this was an important webcast to host. … minutes at the end. … I will be discussing the use of analytic hierarchy process, the stage of which was set very nicely … The gain for going from five months to ten months in progression free survival in renal cell carcinoma … specific question for you, Reed, is how do you manage to get patient input on things like treatment for renal

162. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - were no clear differences between fluorescent cystoscopy and white light cystoscopy in the risk of renal … tumor stage. … Fluorescent vs. white light cystoscopy: renal and genitourinary adverse events Low There were no … clear differences between fluorescent cystoscopy and white light cystoscopy in risk of renal and genitourinary … Surveillance, Epidemiology and End Results Program: Turning Cancer Data Into Discovery.

163. Physiologic Predictors of the Need for Trauma Center Care: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/predictors-trauma-care/research-protocol
     December 01, 2019 - several additional factors such as age, prior conditions (e.g., anticoagulation and bleeding disorders, end-stage … renal disease, pregnancy >20 weeks), burns with or without trauma, and EMS judgement and recommends … The end points or "outcomes" of interest are the predictive utility of the measures. … ("tissue oxygen saturation" or "end-tidal" or "lactate").mp. … ("tissue oxygen saturation" or "end-tidal" or "lactate").mp.

164. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
     December 15, 2010 - aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) o Renal … disease, with known cardiovascular disease; participants with diabetes; participants with hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

165. Disposition of Comments for CER 152 Nonmetastatic Muscle-Invasive Bladder Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_disposition-comments.pdf
     June 30, 2015 - included was carboplatin/gemcitabine as chemotherapy. while this is commonly used for those with renal … compared to no or limited PLND Q3b – SWOG 8710 did report a significant benefit when risk stratified by stage … SWOG 8710 (Grossman et al) found no interaction between tumor stage and effects of treatment, as … Between 1/2014 and the end of 2015 there has been and will be more new data now with respect to biomarkers

166. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - o Studies of only patients with disease reflects the extreme end of the spectrum of disease severity … o Studies of only patients with disease reflects the extreme end of the spectrum of disease severity … Serum free light chain measurements move to center stage. … Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high … Failure Due to Myeloma Cast Nephropathy Recruiting Chronic renal failure with uremic nephropathy

167. Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/venous-ulcers-treatment/research-protocol
     December 01, 2019 - antibiotics (KQ 2) Allergic and hypersensitivity reactions Drug toxicity (not allergic) Major—renal … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Table 3 Table 3

168. Physiologic Predictors of the Need for Trauma Center Care: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
     May 31, 2017 - several additional factors such as age, prior conditions (e.g., anticoagulation and bleeding disorders, end-stage … renal disease, pregnancy>20 weeks), burns with or without trauma, and EMS judgement and recommends … such as complexity/variability of heart rate, tissue O2 saturation, mean arterial pressure, lactate, end-tidal … limited to respiration rate, tissue O2 saturation, respiratory effort, measure of acidemia (e.g., end-tidal … The end points or “outcomes” of interest are the predictive utility of the measures.

169. Medication Therapy Management | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management/research-protocol
     December 01, 2019 - 2013, this criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stage … renal disease were the added conditions. … Because of the stage of the science in this area, we anticipate that the benefit from conducting a systematic … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal … Because of their role as end-users, individuals are invited to serve as Key Informants, and those who

170. Hepatitis-C Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
     November 01, 2012 - refers to the cross-linking of polyethylene glycol molecules to the interferon molecule, which delays renal … harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … performed in groups stratified by HCV genotype as well as by race, age, body weight, viral load, stage … improvement in measures related to quality of life (generic or disease-specific) 24 weeks after the end … Low bid = twice daily; CI = confidence interval; ESLD = end-stage liver disease; HCC = hepatocellular

171. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
     September 13, 2012 - Major—renal toxicity, hepatic toxicity, gastrointestinal upset c. … Source: www.effectivehealthcare.ahrq.gov Published Online: September 13, 2012 Key Informants are the end-users … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … multiple daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Abbreviations: C. diff

172. Medication-Therapy-Management Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
     January 01, 2014 - 2013, this criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stage … renal disease were the added conditions. … Because of the stage of the science in this area, we anticipate that the benefit from conducting a systematic … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal … Because of their role as end-users, individuals are invited to serve as Key Informants, and those who

173. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - include the microvascular complications of retinopathy and blindness, neuropathy, nephropathy, and end-stage … pressure and heart rate, and for studies that include a comparison with SGLT-2 inhibitors, impaired renal … The exclusion criteria were generally similar for most trials: significant renal, cardiovasular, and … rosiglitazone and pioglitazone, are contraindicated in patients with serious or severe heart failure (Stage … 3 or Stage 4) according to product labels.54, 55 We had low or insufficient strength of evidence for

174. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
     November 27, 2012 - With such a large population progressing toward end-stage liver disease we need to find these people … needlessly suffer and our healthcare system will be further overburdened and, frankly, overrun, with end-stage … screening becomes irrelevant because a substantial proportion of HCV patients will have developed end-stage … Stage Renal Disease. … I have seen many many hospitalized patients with end stage liver disease who are alcoholics AND have

175. Machine Learning Methods in Systematic Reviews: Identifying Quality Improvement Intervention Evaluations (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
     September 01, 2012 - While adherence improved, many patients still failed to receive 100% indicated treatments at the end … Health care institutions struggle with the challenge of providing excellent palliative and end-of-life … BACKGROUND: High quality end-of-life care in the community is achieved with effective multidisciplinary … BACKGROUND: Chronic renal failure and haemodialysis treatment is a long-term process; patients need … become established in partnership working; the collaborative approach to providing palliative care for end-stage

176. CER 45 Self-Measured Blood Pressure Monitoring Comparative Effectiveness Surveillance Final 4.7.16 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
     April 11, 2016 - Effects"on"office"and"home"blood"pressure" of"the"lercanidipine'enalapril"combination"in"patients"with"Stage … Blood"pressure"changes"after"renal"denervation"at"10"European"expert" centers." … Abstracts"from"relevant"literature"are"included"at"the"end"of"the"attached" document." … $Abstracts$are$provided$for$included$literature$at$the$end$of$ the$document.$ Conclusions(From(Original … Usual(Care:( Clinical(Outcomes( SOE:(Insufficient( ( One$quality$C$study$reported$ on$mortality$and$end"stage

177. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
     April 01, 2013 - refers to the cross-linking of polyethylene glycol molecules to the interferon molecule, which delays renal … improvement in measures related to quality of life (generic or disease-specific) 24 weeks after the end … Low Note: CI=confidence interval, ESLD=end-stage liver disease, HCC=hepatocellular carcinoma, HCV=hepatitis … week 8 Alanine aminotransferase and aspartate aminotransferase normalization: in normal range at end … in relation to Interleukin 28B (IL28-b) expression Incidence of anemia Response rate (rapid/early/end

178. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with renal failure Interventions … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age, race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage

179. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with renal failure Interventions … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age, race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage

180. Behavioral Programs for Diabetes Mellitus | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-behavior-programs/research-protocol
     December 01, 2019 - glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … propose the following time points, but will seek input from the TEP to confirm their appropriateness: end … Key Informants Key informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as key informants and those who